Anika to Participate in Upcoming Virtual Investor Conferences

Rhea-AI Summary

Anika Therapeutics, a joint preservation and regenerative solutions company based in Bedford, Massachusetts, has announced participation in four virtual investor conferences in September 2020. Key executives, Dr. Cheryl R. Blanchard and Michael Levitz, will engage in various sessions. Notably, Dr. Blanchard will deliver a fireside chat at the Wells Fargo Healthcare Conference on September 10 and the Morgan Stanley Global Healthcare Conference on September 17. Live audio webcasts will be available on the company's Investor Relations website.

BEDFORD, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care, today announced that Cheryl R. Blanchard, Ph.D., President and Chief Executive Officer, and Michael Levitz, Chief Financial Officer, will participate in the following four virtual investor conferences in September:

• Barrington Research Fall Investment Conference on Wednesday, September 9, 2020. Dr. Blanchard and Mr. Levitz will participate in virtual one-on-one meetings with investors.
• Wells Fargo Healthcare Conference on Thursday, September 10, 2020. Dr. Blanchard is scheduled to participate in a fireside chat at 10:40 a.m. ET.
• Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2020. Dr. Blanchard is scheduled to participate in a fireside chat at 8:45 a.m. ET.
• Sidoti Investor Conference on Thursday, September 24, 2020. Dr. Blanchard is scheduled to present at 9:15 a.m. ET.

Live audio webcasts of the Wells Fargo, Morgan Stanley and Sidoti presentations may be accessed via the "Investor Relations" section of Anika’s website, www.anikatherapeutics.com. Audio archives of the presentations also will be available on the website.

About Anika Therapeutics, Inc.

Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global, integrated joint preservation, restoration and regenerative solutions company based in Bedford, Massachusetts. Anika is committed to delivering products along the orthopedic early intervention continuum of care to improve the lives of patients, with a focus on osteoarthritis pain management, sports medicine and joint preservation, restoration and regeneration. The Company has close to three decades of global expertise commercializing innovative products across the orthopedic early intervention continuum of care. For more information about Anika, please visit www.anikatherapeutics.com.

For Investor Inquiries: Anika Therapeutics, Inc. Kristen Galfetti, 781-457-9000 Executive Director, Investor Relations investorrelations@anikatherapeutics.com

For Media Inquiries: W2O Group Rachel Girard, 617-379-6760   rgirard@w2ogroup.com

 

FAQ

What are the upcoming investor conferences for Anika Therapeutics in September 2020?

Anika Therapeutics will participate in four virtual investor conferences: Barrington Research on September 9, Wells Fargo on September 10, Morgan Stanley on September 17, and Sidoti on September 24.

Who from Anika Therapeutics will speak at the Wells Fargo Healthcare Conference?

Dr. Cheryl R. Blanchard, President and CEO, is scheduled to participate in a fireside chat at the Wells Fargo Healthcare Conference on September 10, 2020.

When will Anika Therapeutics hold its presentations at investor conferences?

Presentations will take place on September 9, 10, 17, and 24, 2020, with specific times for each conference.

How can I access live audio webcasts of Anika Therapeutics' presentations?

Live audio webcasts of the presentations can be accessed via the Investor Relations section of Anika Therapeutics' website.

What is the focus of Anika Therapeutics' product offerings?

Anika Therapeutics specializes in joint preservation, restoration, and regenerative solutions, with a focus on osteoarthritis pain management and sports medicine.